Literature DB >> 6201336

Objective measurement of hepatic encephalopathy by means of automated EEG analysis.

C C Van der Rijt, S W Schalm, G H De Groot, M De Vlieger.   

Abstract

Automated analysis of the electroencephalogram as an objective measurement of hepatic encephalopathy for the individual patient was investigated. The mean dominant frequency of patients with grades 0 and 1 hepatic encephalopathy was in the normal range (greater than or equal to 6.4 Hz); grade 1 hepatic encephalopathy, however, was characterized by abnormal relative power of theta activity of more than 35%. Twelve out of 34 patients with clinical grade 0 hepatic encephalopathy also had an elevated power of theta activity and probably therefore latent hepatic encephalopathy. Patients with grades 2, 3 and 4 hepatic encephalopathy had a low mean dominant frequency (less than 6.4 Hz) and could be identified by a biphasic power spectrum (theta and delta peaks, grade 2) or by a high power of delta activity (greater than or equal to 70%, grade 3-4). We conclude that automated EEG analysis based on the parameters mean dominant frequency and the relative powers of the delta and theta band is very suitable for objective classification of hepatic encephalopathy in individual patients.

Entities:  

Mesh:

Year:  1984        PMID: 6201336     DOI: 10.1016/0013-4694(84)90071-3

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  34 in total

Review 1.  Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.

Authors:  T Gerber; H Schomerus
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil.

Authors:  E A Jones; V I Giger-Mateeva; D Reits; F C Riemslag; B Liberov; H Spekrijse
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 3.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 4.  Neurophysiological investigation of hepatic encephalopathy.

Authors:  Piero Amodio; Angelo Gatta
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 5.  Neural synchronization in hepatic encephalopathy.

Authors:  Lars Timmermann; Markus Butz; Joachim Gross; Gerald Kircheis; Dieter Häussinger; Alfons Schnitzler
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

6.  Effects of L-carnitine in patients with hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Giovanni Pistone; Rampello Elvira; Carmelo Leotta; Linda Scarpello; Rampello Liborio
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 7.  EEG and event related potentials in hepatic encephalopathy.

Authors:  M G Davies; M J Rowan; J Feely
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

8.  Brain mapping analysis in patients with hepatic encephalopathy.

Authors:  T Sagalés; V Gimeno; M D de la Calzada; F Casellas; M Dolors Macià; M Villar Soriano
Journal:  Brain Topogr       Date:  1990       Impact factor: 3.020

9.  Memory impairment in patients with cirrhosis.

Authors:  Funda Bahceci; Bulent Yildirim; Melih Karincaoglu; Ibrahim Dogan; Birsen Sipahi
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

Review 10.  Diagnosis of minimal hepatic encephalopathy.

Authors:  Karin Weissenborn
Journal:  J Clin Exp Hepatol       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.